International Clinical Trial: An 8-week, Multi-center, Randomized, Double-blind, Placebo-Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of NPK-CBS on Improving Immune Function

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (KCT0011827) titled 'An 8-week, Multi-center, Randomized, Double-blind, Placebo-Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of NPK-CBS on Improving Immune Function' on April 9.

Study Type: Interventional Study

Study Design: Primary Purpose : Other(This human application test was planned to evaluate the effectiveness and safety of improving immune function compared to Placebo when NPK-CBS was ingested in people with normal or slightly lowered wh), Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Outcome Accessor, Allocation : RCT

Primary Sponsor: Soon Chun Hyan...